4
Changes in Ownership
Neurogene Inc. Filed Acc 0001209191-18-020680
Chief Operating Officer sold 1,302 shares at $14.63 ($19,049)
- Chief Operating Officer acquired 1,302 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
MacKenzie Lloyd · Chief Operating Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-03-15 | Exercise or conversion : show line 1 in the form | +1,302 | $10.56 | $13,749 | 1,302 | D |
| 2018-03-15 | Sale : show line 2 in the form | −1,302 | $14.63 | $19,049 | 0 | D |
| Open-market sales · 1,302 sh · avg $14.63 · $19,049 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-03-15 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −1,302 | 0 | D |
Loading xslF345X03/doc4.xml…